Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals (REGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Regeneron Pharmaceuticals 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 USA

P: 914-847-7000

Description:

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of obesity, rheumatoid arthritis, cancer, and asthma and has preclinical programs in other diseases and disorders.

Key Statistics

Overview:

Market Capitalization, $K 32,513,272
Shares Outstanding, K 109,831
Annual Sales, $ 6,711 M
Annual Net Income, $ 2,444 M
Last Quarter Sales, $ 1,934 M
Last Quarter Net Income, $ 193,100 K
60-Month Beta 1.15
% of Insider Shareholders 11.84%
% of Institutional Shareholders 65.85%
Float, K 96,827
% Float 88.16%

Growth:

1-Year Return -21.50%
3-Year Return -26.54%
5-Year Return -15.53%
5-Year Revenue Growth 218.84%
5-Year Earnings Growth 169.75%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 6.02 on 08/06/19
Next Earnings Date N/A
Earnings Per Share ttm 20.06
EPS Growth vs. Prev Qtr 41.07%
EPS Growth vs. Prev Year 12.55%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

REGN Ratios

Ratio
Price/Earnings ttm 14.87
Price/Earnings forward 20.78
Price/Earnings to Growth 1.36
Return-on-Equity (After Tax) 25.79
Return-on-Assets (Before Tax) 19.02
Profit Margin % 36.42
Net Margin % -33.60
Debt/Equity 0.08
Price/Sales 4.88
Price/Cash Flow 13.43
Price/Book 3.36
Book Value/Share 88.87
Interest Coverage 91.55
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar